Contributor list
1 The vascular endothelium in diabetes
Andrew Lansdown, Elizabeth Ellins, Julian Halcox
2 New Biomarkers of Cardiovascular Disease in Diabetes
Hitesh Patel, Sujay Chandran, Kausik K. Ray
3 Kidney Disease in Diabetes
Amanda Y. Wang, Meg Jardine, and Vlado Perkovic
4 Vascular imaging
Kiyoko Uno, Jordan Andrews and Stephen J Nicholls
5 Glycaemia and CVD and its management
Jeffrey W. Stephens, Akhila Mallipedhi, Stephen C. Bain
6 Hypertension and cardiovascular disease and its management
José A. García-Donaire and Luis M. Ruilope
7 Dyslipidaemia and its Management in Type 2 Diabetes
D. John Betteridge
8 Thrombosis in diabetes and its clinical management
RA Ajjan and Peter J. Grant
9 Diet and Lifestyle in CVD Prevention and Treatment
Alice H. Lichtenstein
10 Management of acute coronary syndrome
Christopher M. Huff and A. Michael Lincoff
11 Management of Peripheral Arterial Disease
Rüdiger-Egbert Schernthaner, Gerit-Holger Schernthaner, Guntram
Schernthaner
Index
D John Betteridge is Emeritus Professor of Endocrinology,
Department of Medicine, UCLH, London, and Consultant Physician,
University College Hospitals Foundation Trust, London, UK.
He is a past Chairman of the British Hyperlipidaemia Association
and past President of the Council on Lipids in Clinical Medicine at
The Royal Society of Medicine. He is a committee member of the
European Chapter and elected Distinguished Fellow of the
International Atherosclerosis Society. He is a Fellow of the
American Heart Association and a member of numerous international
bodies, including the European and American Diabetes Associations
and the European Atherosclerosis Society. He is co-chair of the
executive committee of CARDS, a major primary CVD prevention trial
with atorvastatin in type 2 diabetes. He is the UK Principal
Investigator and member of the International Steering Committee for
PROactive a major secondary prevention trial with pioglitazone in
type 2 diabetes. He is a member of the Joint European Society of
Cardiology and European Association for the Study of Diabetes
Taskforce on Diabetes and Vascular Disease and was a member of the
Medical Research Council Steering Committee for the UKPDS. He was a
member of the Project Grants Committee of the British Heart
Foundation (2005-2009).
Professor Betteridge's clinical interests are in the care of
patients with diabetes mellitus and lipid disorders. His main
research interests relate to the pathogenesis of atherosclerosis,
in particular the role of lipoprotein metabolism. He has authored
over 300 publications in peer-reviewed journals. His books include
Lipoproteins in Health and Disease (Edward Arnold, 1999), Diabetes:
Current Perspectives (Martin Dunitz, 2000), Lipids and Vascular
Disease (Martin Dunitz, 2000), Case Studies in Diabetes (Martin
Dunitz, 2003), Lipids and Coronary Heart Disease (Arnold, 2003) and
Case Studies in Lipid Management (Informa Healthcare ) 2006.
Stephen Nicholls is Professor of Cardiology, University of
Adelaide and Consultant Cardiologist, Royal Adelaide Hospital,
Adelaide, Australia.
Formerly Medical Director of Intravascular Ultrasound and
Angiography and Clinical Director of the Cleveland Clinic Center
for Cardiovascular Diagnostics and Prevention in the US, Dr.
Nicholls is a leading international figure in cardiovascular
disease and cardiovascular imaging. A fellow of both the Royal
Australasian College of Physicians and the American College of
Cardiology, he received the Helen May Davies Research Award from
the National Heart Foundation of Australia, the Young Investigator
Award at the 13th International Symposium on Atherosclerosis and
was a finalist for the Samuel A. Levine Clinical Young Investigator
Award at the 2005 Annual Scientific Sessions of the American Heart
Association. His interests include the functional properties of
HDL, the role of inflammation and oxidative stress in atherogenesis
and the development of new imaging modalities to assess factors
that influence the natural history of atherosclerosis. He plays a
lead role in clinical trials that employ intravascular ultrasound
to investigate the impact of novel anti-atherosclerotic therapies.
He has had 94 journal articles published.
“I cannot recommend this volume highly enough – you can actually feel your brain expanding as you read. For those who have even a slight interest in heart disease and diabetes, it will make you an authority on the subject – if you can concentrate for long enough!.” (Diabetic Update, 1 April 2015)
Ask a Question About this Product More... |